Protalix BioTherapeutics financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

프로탈릭스 바이오테라퓨틱스NYSEAMERICAN:PLX · NYSE Amex · Healthcare · sector #16

$2.73+0.74%

2026-10-06 close · prelim

Protalix BioTherapeutics's published financial data is dated 2026-10-04. 2024 revenue was $53M. 2024 operating profit was $4M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy